Literature DB >> 7294508

Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo.

M R Knowles, J L Carson, A M Collier, J T Gatzy, R C Boucher.   

Abstract

Nasal transepithelial electrical potential difference (PD) was estimated in vivo in normal human subjects. The PD between a bridge perfused with Ringer's solution placed on the nasal mucosal surface and a reference electrode in a subcutaneous space was recorded. The magnitude of the PD depended upon the region of the nasal cavity touched by the exploring bridge. The PD values ranged from -4 mV (lumen negative) on the anterior tip of the inferior turbinate to approximately -30 mV on the inferior surface of the turbinate. Biopsies of the anterior turbinate were characterized by squamous epithelial cells, whereas ciliated cells dominated the epithelium from regions of higher PD. Epithelial abrasion abolished PD. No differences in PD were noted between the left and right nasal cavities, and repetitive measurements of PD at the same site yielded comparable values. No differences in nasal PD were noted between young male or female subjects but PD declined as a function of age. Amiloride (10(-4)M) and lidocaine (10(-1)M) reduced PD (-59% and -30%, respectively), whereas amphotericin B (5 X 10(-5)M) raised PD (+29%). We concluded that nasal PD can be accurately measured in vivo in humans, and that measurements of nasal bioelectric properties may serve as a relatively noninvasive index of respiratory epithelial function.

Entities:  

Mesh:

Year:  1981        PMID: 7294508     DOI: 10.1164/arrd.1981.124.4.484

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  32 in total

1.  Active transport of polypeptides in rabbit nasal mucosa: possible role in the sampling of potential antigens.

Authors:  D Cremaschi; C Rossetti; M T Draghetti; C Manzoni; V Aliverti
Journal:  Pflugers Arch       Date:  1991-11       Impact factor: 3.657

2.  Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience.

Authors:  J Tod Olin; Kim Burns; Johnny L Carson; Hilda Metjian; Jeffrey J Atkinson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Carlos E Milla; Kenneth N Olivier; Margaret Rosenfeld; Brock Baker; Margaret W Leigh; Michael R Knowles; Scott D Sagel
Journal:  Pediatr Pulmonol       Date:  2011-01-31

3.  Abnormalities of nasal potential difference measurement in Liddle's syndrome.

Authors:  E Baker; X Jeunemaitre; A J Portal; P Grimbert; N Markandu; A Persu; P Corvol; G MacGregor
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

4.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

5.  Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung.

Authors:  Ahmed Lazrak; Asta Jurkuvenaite; Lan Chen; Kim M Keeling; James F Collawn; David M Bedwell; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-08       Impact factor: 5.464

6.  Locally deposited but not inhaled frusemide reduces nasal potential difference in healthy subjects.

Authors:  P Mialon; R Charfi; J Regnard; A Lockhart; A T Dinh-Xuan
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Movement of electrolytes and fluid across airways.

Authors:  I Nathanson; J A Nadel
Journal:  Lung       Date:  1984       Impact factor: 2.584

Review 8.  Role of endothelin-1 in acute lung injury.

Authors:  Alejandro P Comellas; Arturo Briva
Journal:  Transl Res       Date:  2009-03-20       Impact factor: 7.012

9.  Relative ion permeability of normal and cystic fibrosis nasal epithelium.

Authors:  M Knowles; J Gatzy; R Boucher
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

Review 10.  The impact of respiratory viral infections in patients with cystic fibrosis.

Authors:  C G Prober
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.